Development and Validation of Minimal Disease Activity, Disease Flare, and Minimal Clinically Important Difference for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach
Nuruzzaman, F.; Rosenwaser, N.; Wang, X.; Akikusa, J. D.; Basiaga, M. L.; Klein, A.; Muse, I.; Balay-Dustrude, E.; Nguyen, M.; Deng, E.; Lenert, A.; Bergstrom, L.; Dedeoglu, F.; Huang, B.; King, J.; Lapidus, S.; Lee, T. C.; Levesque, C. M.; Lim, L.; Martin, K.; Murray, E.; Oliver, M. S.; Onel, K. B.; Ozen, S.; Potts, L.; Stern, S. M.; Villaverda, R.; Wu, E. Y.; Laxer, R. M.; Ferguson, P. J.; Lovell, D. J.; Zhao, Y.; CHOIR network, ; CARRA CNO workgroup,
Show abstract
ObjectivesTo create definitions for minimal disease activity (MDA), flare, and minimal clinically important difference (MCID) for chronic nonbacterial osteomyelitis (CNO). It is necessary to establish these criteria prior to starting clinical effectiveness trials for therapies in CNO. MethodsThree separate cohorts samples from an international observational CNO registry were presented to a panel of twenty experts in CNO, including 7 patients/caregivers via online and in-person voting using nominal group technique to define MDA, flare, and MCID, respectively. Experts classified the cases in each cohort as meeting the state for that specific cohort, ie. MDA or not, or flare or not, or meeting MCID or not. A consensus of [>=]80% was required. ResultsGeneral surveys identified the most important variables to include to define MDA, flare, and MCID. Clinical improvement of 30% or more in these critical parameters and improvement of CNO Clinical Disease Activity Score (CDAS) by at least 3 were considered meaningful by providers and consensus data. Conclusions This study provides the preliminary definitions of MDA, disease flare, and MCID in CNO which can serve as targets and potential outcomes from treatments. These definitions must now be validated in other cohorts and tested in clinical trials. Key MessagesO_ST_ABSWHAT IS ALREADY KNOWN ON THIS TOPICC_ST_ABSO_LIMeasurements of minimal disease activity (MDA), worsening disease activity ( flare), and minimally clinically important differences (MCID) in CNO are not well-established. For successful execution of clinical trials to identify effective treatment strategies in patients with CNO, standardized definitions of these terms are necessary. C_LI WHAT THIS STUDY ADDSO_LIUsing data from an international real-world registry of CNO patients, we developed and validated quantitative definitions for MDA, flare, and MCID. C_LI HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICYO_LIDefinitions of MDA, flare, and MCID will serve as potential outcomes in future clinical trials to study effectiveness of therapies in CNO. C_LI
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Incorporating computer vision on smart phone photographs into screening for inflammatory arthritis: results from an Indian patient cohort 94%
- Prodromal symptoms of rheumatoid arthritis in a primary care database: variation by ethnicity and socioeconomic status 93%
- A new indicator to measure discordance between patient reported outcomes and traditional disease activity holds promise to advance care trajectories improve care in patients with early Rheumatoid Arthritis 93%
Similar papers in this journal
- Risk factors for hospital admission related to COVID-19 in inflammatory rheumatic diseases 93%
- Management of rheumatic diseases in the times of COVID-19 pandemic- perspectives of rheumatology practitioners from India 93%
- Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study 93%
Similar papers in this journal
- SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Pediatric Rheumatology Database in Germany 95%
- Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care 93%
- Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease 93%
Similar papers in this journal
- Refractory Inflammatory Arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process 96%
- “The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica” 92%
- Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses 92%
Similar papers in this journal
- Discontinuity of care and trust in usual physician among patients with systemic lupus erythematosus 94%
- Detecting radiographic sacroiliitis using deep learning with expert-level accuracy in axial spondyloarthritis 92%
- Intra-Articular Delivery of an Indoleamine 2,3-Dioxygenase Galectin-3 Fusion Protein for Osteoarthritis Treatment in Male Lewis Rats 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.